Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has informed BSE that its Board of Directors will meet on Monday, 26 May 2025, to consider and approve the audited financial results for the quarter and year ended 31 March 2025. The trading window for the company's equity shares has been closed since 15 April 2025 and will reopen 48 hours after the results are publicly disclosed on 28 May 2025. This is a standard regulatory intimation under SEBI LODR Regulation 29(1)(a). No financial figures, outcomes, or material developments are disclosed in this filing. The intimation is signed by Managing Director Mr. Aalap Prajapati.
This is a routine advance notice ahead of the FY25 earnings announcement and carries no direct impact on shareholders. Investors should wait for the actual audited results on 28 May 2025 for any meaningful signals on revenue, profitability, or dividend.